Department of Medicine

Study tracks therapy to slow idiopathic pulmonary fibrosis

Investigators in the Division of Allergy, Pulmonary and Critical Care have launched a pilot study to see if patients with idiopathic pulmonary fibrosis (IPF) can tolerate the addition of a commonly used antiviral drug to standard IPF treatments. The research team believes the drug may ultimately help slow progression of the chronic and progressive disease or reverse its course.

NEJM Catalyst forum addresses mental, behavioral and social health determinants

Healthcare is more than diagnosing and treating disease. To truly improve health outcomes for individuals and communities, the mental, behavioral and social determinants of health must be fully integrated with physical factors at all levels of the healthcare system.

Personalized drug prescribing program expands, upgrades

Vanderbilt University Medical Center (VUMC) has expanded and relaunched genetic testing to predict patient responses to drugs.

trailer park

Study finds higher death rates in poor neighborhoods

Living in an economically disadvantaged neighborhood is likely to lead to death at an earlier age, especially among African-Americans, new research shows. The death rate is even more pronounced among disadvantaged individuals with unhealthy lifestyle habits.

Wang set to lead cardiology association

Thomas Wang, MD, Gottlieb C. Friesinger II Professor of Cardiovascular Medicine and director of the Division of Cardiovascular Medicine, was recently named president-elect of the Association of Professors of Cardiology (APC) for 2018. He will subsequently serve as the president of the group in 2019.

Iconic Baltimore inner city row houses.

Heart failure risk predicted by communities, not wealth

When buying and selling real estate, how often have you heard the realtor’s mantra — location, location, location? This is also the central theme of a recently released journal report on factors that can predict heart failure risk.

1 76 77 78 79 80 116